The paper extends the current body of research in several directions:
• First, we provide more recent prevalence estimates of chronic migraine.
• Second, we examine the medical treatment costs by source of care and the prevalence of the use of different sources of care.
• Third, we examine the prevalence of comorbid conditions and their financial treatment and workplace productivity implications.
• Finally, we examine the impact that chronic migraine has on the treatment costs of patients with both chronic migraine and other comorbid conditions.
Read the full paper here.